Immunological Profiles, Oxidative Stress Biomarkers and Plasma Cholinesterase Activities in Patients with Immune-Mediated Inflammatory Diseases Treated in a Clinic in Duhok, Iraq

1 Monteleone G, Moscardelli A, Colella A, et al. Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features. Autoimmun Rev. 2023; 22(10):103410. Search in Google Scholar

2 Ortega MA, García-Montero C, Fraile-Martinez O, et al. Immune-mediated diseases from the point of view of psychoneuroimmunoendocrinology. Biology (Basel). 2022; 11(7):973. Search in Google Scholar

3 Hysa E, Lercara A, Cere A, et al. Temporomandibular disorders in immune-mediated rheumatic diseases of the adult: A systematic review. Semin Arthritis Rheum. 2023; 61:152215. Search in Google Scholar

4 Rahman P, Inman RD, El-Gabalawy H, et al. Pathophysiology and pathogenesis of immune-mediated inflammatory diseases: commonalities and differences. J Rheumatol Suppl. 2010; 85:11-26. Search in Google Scholar

5 Ginard-Vicens D, Tornero-Molina J, Fernández-Fuente-Bursón L, et al. Patient preferences in chronic immune-mediated inflammatory diseases potentially treated with biological drugs: discrete choice analysis using real-world data analysis. Expert Rev Pharmacoecon Outcomes Res. 2023; 23(8):959-965. Search in Google Scholar

6 Agrawal M, Spencer EA, Colombel JF, et al. Approach to the management of recently diagnosed inflammatory bowel disease patients: A user’s guide for adult and pediatric gastroenterologists. Gastroenterology. 2021; 161(1):47-65. Search in Google Scholar

7 Guilliams TG, Weintraub J. Implementing Personalized Dietary Interventions for Immune-Mediated Inflammatory Diseases. Integr Med (Encinitas). 2023; 22(5):18-26. Search in Google Scholar

8 Brown P, Pratt AG, Hyrich KL. Therapeutic advances in rheumatoid arthritis. BMJ. 2024;384: e070856. Search in Google Scholar

9 Patel JP, Konanur Srinivasa NK, Gande A, et al. The role of biologics in rheumatoid arthritis: a narrative review. Cureus. 2023; 15(1):e33293. Search in Google Scholar

10 Honap S, Jairath V, Danese S, et al. Navigating the complexities of drug development for inflammatory bowel disease. Nat Rev Drug Discov. 2024 May 22. Search in Google Scholar

11 Shellard EM, Rane SS, Eyre S, et al. Functional genomics and insights into the pathogenesis and treatment of psoriasis. Biomolecules. 2024;14(5): 548. Search in Google Scholar

12 Vebr M, Pomahaþová R, Sýkora J, et al. A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. Biomedicines. 2023; 11(12):3229. Search in Google Scholar

13 Zhou Y, Cao T, Li Z, et al. Fibroblasts in immune-mediated in-flammatory diseases: The soil of inflammation. Clin Immunol. 2024; 258:109849. Search in Google Scholar

14 Schett G, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med. 2021; 385(7):628-639. Search in Google Scholar

15 Das UN. Acetylcholinesterase and butyrylcholinesterase as markers of low-grade systemic inflammation. Ann Hepatol. 2012; 11(3):409-4011. Search in Google Scholar

16 Milstoc M. Cholinesterase activity in patients with rheumatoid arthritis. Am J Clin Pathol. 1970 Apr;53(4):452-7. doi: 10.1093/ajcp/53.4.452. Search in Google Scholar

17 Wang DW, Zhou RB, Yao YM. Role of cholinergic anti-inflammatory pathway in regulating host response and its interventional strategy for inflammatory diseases. Chin J Traumatol. 2009; 12(6):355-364. Search in Google Scholar

18 Abdullah RG, Eassa SH, Mohammad FK. Plasma cholinesterase activity in patients with rheumatoid arthritis and toxoplasmosis. Cureus. 2023; 15(12):e50979. Search in Google Scholar

19 Weber BN, Garshick M, Abbate A, et al. Acute cardiovascular complications of immune-mediated systemic inflammatory diseases. Eur Heart J Acute Cardiovasc Care. 2023; 12(11):792-801. Search in Google Scholar

20 Nune A, Durkowski V, Pillay SS, et al. New-onset rheumatic immune-mediated inflammatory diseases following SARSCoV-2 vaccinations until May 2023: A systematic review. Vaccines (Basel). 2023; 11(10): 1571. Search in Google Scholar

21 Zhang H, Qiao W, Liu R, et al. Development and validation of a novel biomarker panel for Crohn’s disease and rheumatoid arthritis diagnosis and treatment. Aging (Albany NY). 2024; 16(6):5224-5248. Search in Google Scholar

22 Kasim HF, Salih HM, Eassa SH. Adherence to biologic drugs among patients with immune mediated inflammatory diseases in Duhok governorate. Duhok Med J. 15Aug.2020; 14(1): 63-66. Search in Google Scholar

23 Kasim HF, Salih HM, Eassa SH. Detection of anti-infliximab antibodies and identifying factors affecting their occurrence using Elisa method among patients with immune-mediated inflammatory diseases. Ind J Foren Med Toxicol. 2021; 15(3):3047-3058. Search in Google Scholar

24 Odisho SK, Mohammad FK. Blood cholinesterase activities and oxidative stress status among farmworkers using pesticides in Duhok, KRG, Iraq. J Ideas Health. 2022; 5(4):786-793. Search in Google Scholar

25 Mohammad FK. Clarifying an electrometric method for determining blood cholinesterase activity: a scientific letter. Asia Pac J Med Toxicol. 2022; 11(1):30-32. Search in Google Scholar

26 Hammer Ø, Harper DAT, Ryan PD. PAST: paleontological statistics software package for educaton and data anlysis. Palaeontol Electron. 2001; 4(1):1. Search in Google Scholar

27 Mukaka MM. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012; 24(3):69-71. Search in Google Scholar

28 GBD 2019 IMID Collaborators. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. EClinicalMedicine. 2023; 64:102193. Search in Google Scholar

29 Wójcik P, GĊgotek A, Žarkoviü N, et al. Oxidative stress and lipid mediators modulate immune cell functions in autoimmune diseases. Int J Mol Sci. 2021; 22(2):723. Search in Google Scholar

30 Wang W, Huang M, Ge W, et al. Identifying serum metabolite biomarkers for autoimmune diseases: a two-sample Mendelian randomization and meta-analysis. Front Immunol. 2024; 15:1300457. Search in Google Scholar